In the present article we report the generation of a neurovirological reagent, an adenovirus vector that ef ciently delivers the gene for the Neurotrophin-3 (NT-3) receptor, TrkC. Using this AdTrkC vector, we examined the induction of the expression of the above neurotrophin receptor in pure cultures of mouse astrocytes, a glial cell type that does not constitutively express this gene. Infection of astrocytes at an optimal dose of 100 ±200 plaque forming units 
Introduction
Neurotrophins mediate their trophic activities through the Trk family of tyrosine kinase receptors (Barbacid, 1993) . The TrkC gene product, gp145 trkC , is a high af®nity receptor for neurotrophin-3 (NT-3), a member of the neurotrophin factors family (Lamballe e t a l, 1991 (Lamballe e t a l, , 1993 . The TrkC locus is expressed in both the embryonic and adult central and peripheral nervous systems (Lamballe e t a l, 1991) . Nevertheless, when chicken E11 sympathetic neurons are cultured in the presence of p75 NTR is the only detectable NT-3 receptor (Dechant e t a l, 1997) , and in the absence of TrkC, NT-3 uses TrkA instead (Cordon-Cardo e t a l, 1991).
Although astrocytes produce NT-3 mRNA (Rudge e t a l, 1992) and it is suggested that might secrete NT-3 (Barres e t a l, 1994) , no full-length TrkC and only a low level of expression of the truncated form of TrkC, incapable of signal transduction, is found in those cells (Rudge e t a l, 1994) .
NT-3 gene targeting induces severe sensory and sympathetic de®cits (Ernfors e t a l, 1994; Farin Ä as e t a l, 1994) , as well as death of spinal sensory neurons in mice (Farin Ä as e t a l, 1996) . Furthermore, disruption of the TrkC gene eliminates group Ia muscle afferents and results in abnormal movements of knockout' mice (Klein e t a l, 1994 ). An important role in oligodendrocyte development has been also proposed for NT-3 (Barres e t a l, 1994) . In addition, de®cienc ies in astrocyte development were observed in NT-3 and TrkC double`knockout' mice, suggesting that both play some role in the proliferation of such glial population (Kahn e t a l, 1999) .
S uccessful gene transfer in the central nervous system (CNS) is dependent on ef®cient methods of introducing a particular transgene into the appropriate population of neuronal or glial cells. This poses an exceptional challenge since the CNS contains a wide range of cell types and post-mitotic neural cells are refractory to transduction with classical retroviral vectors or are infected with limited ef®ciency (Luskin e t a l, 1988) . Gene transfer to several neural cells can be achieved by using adenoviral vectors. These vectors are not dependent on host cell replication and allow expression of a foreign gene in a wide range of post-mitotic cells, including neurons and astrocytes (Akli e t a l, 1993 ; Bajocchi e t a l, 1993; Blo È mer e t a l, 1996; Davidson e t a l, 1993; Hermens e t a l, 1997; Kaplitt and Makimura, 1996 ; Le Gal La Salle e t a l, 1993; Neve, 1993; Ridoux e t a l, 1994; Sabate e t a l, 1995; S mith e t a l, 1995) .
This methodology can be used to modify the physiology of neurons and glial cells in vitro and in vivo (Horellou e t a l, 1994 ; Lawrence e t a l, 1995; Xu e t a l, 1994). For instance, the adenoviral vectormediated expression of NGF has been shown to reduc e the consequences of aging (Castel-Barthe e t a l, 1996). In addition, astrocytes infected with an adenoviral vector encoding NT-3 increased survival of cultured neurons (Smith e t a l, 1996) and adenovirus-directed NT-3 expression in rat dorsal root ganglions induc ed neurite outgrowth (Dijkhuizen e t a l, 1997).
The purpose of the present study was to generate an adenoviral vector encoding TrkC and to demonstrate that this vector can be employed to induce astrocytes to express the receptor for NT-3 in amounts that are suf®cient to result in a biological response in the presenc e of the ligand.
Results

Co nstruc tio n o f th e a d e no viral ve c to r
A recombinant adenovirus carrying a TrkC expression cassette was generated by cotransfection of Cla I and Xb a I restriction digested Ad5 genomic DNA with the plasmid pNR2 (Figure 1 ). Cotransfection was done in 293 cells. Homologous recombination resulted in the formation of several plaques, which were further puri®ed. To con®rm the presenc e of TrkC cDNA in the adeno vector, plaques were subjec ted to PCR with speci®c primers, as stated under Materials and methods. A stock of an AdTrkC selec ted, PCR-positive plaque, was prepared and cesium chloride puri®cation was carried out. The titer of this puri®ed virus was 1´10 10 p.f.u./ml as determined on 293 cells. This stock was employed in all studies reported here.
Ad e no viral infe c tio n o f a stroc yte s
In order to determine whether our primary astrocyte cultures were susceptible to adenovirus infection, we infected them with a control AdRSVbGal vector at different m.o.i. for 24 ± 48 h. Incubation with the X-gal substrate labelled in blue the nuc lei of around 75% of the cultures (not shown). The staining was nearly 100% after a 48 h incubation period in the presenc e of the mitotic inhibitor cytosine arabinofuranoside (Sigma), at a concentration of 10 lM, demonstrating that almost all the cells were susceptible to gene transfer with adenovirus vectors. Therefore, we concluded that under our experimental conditions astrocytes were fully sensitive to adenovirus infection, as previously stated by other authors (Le Gal La S alle e t a l, 1993; Ridoux e t a l, 1994).
Re ve rse tra nscripta se -PCR analysis
The presence of mRNA speci®c for full-l ength TrkC in cultures of mouse astrocytes, either mockinfected or infected at different m.o.i. with the AdTrkC vector for 24 ± 48 h, was studied using an RT ± PCR strategy. The speci®c amplimers described under Materials and methods ampli®ed discrete sequences from the plasmid Bluescript pFL19 (Lamballe e t a l, 1991) which encodes fulllength TrkC (Figure 2 ). This 703 bp fragment encodes the extracellular, transmembrane and tyrosine kinase domains of the 145 000 dalton glycoprotein gp145 trkC , the receptor for NT-3. Uninfected astrocytes do not express physiologically active TrkC, as suggested previously by the fact that NT-3 does not in¯uenc e DNA synthesis in these cells (Barres e t a l, 1994) . Nevertheless, mRNA is fully reverse-transcribed and ampli®ed from cells infected with 10, 100 or 200 p.f.u./cell of our adenovirus vector AdTrkC (Figure 2) . The optimal dose, as detected by TrkC fragment ampli®cation, is a m.o.i. of 200. Negative controls where the Moloney murine leukaemia virus reverse transcriptase was omitted, did not produce any band in the chain reaction, demonstrating that we were actually amplifying mRNA. b-Ac tin ampli®cation was shown as positive control message ampli®cation (Figure 2) .
North e rn blo t a na lysis
Northern blot analysis was used to con®rm the presenc e of transcripts coding for gp145 Previous attempts to induce the expression of TrkC mRNA by astrocyte stimulators including TNF, IL-1 and cAMP failed after treatment with different doses and periods of time (not shown).
We ste rn blots o f 2D ge l e le c tro p h o re sis Urea-extracted proteins from uninfec ted astrocytes or astrocytes transduced with the AdRSVbGal or the AdTrkC vectors were separated by 2D gel electrophoresis. Figure 4 , upper panel, shows the separation of proteins from astrocytes transduced by the adenovirus vector AdTrkC and stained with silver.
Western blots were developed with an anti-panTrk antiserum prepared by immunising rabbits with a synthetic peptide corresponding to the 14 carboxy-terminal residues of TrkA (Martin-Zanca e t a l, 1989). Four different proteins, two of them with two isoforms, showing isoelectric points between 5.2 and 6.7 and molecular weights between 145 000 and 80 000 dalton, were recognised by the anti-Trk antibody (Figure 4, lower panel, arrows) . No antibody staining was observed with the proteins extracted from mock-infec ted astrocyte cultures or from cultures transduced with the control AdRSVb Gal (not shown). 
Figure 4
Silver stained 2D gel electrophoresis of the proteins (10 lg) extracted from AdTrkC-transduced astrocytes (upper panel). The proteins (50 l g) from a gel run in parallel were transferred onto nitrocellulose membranes and developed with a rabbit antibody against the synthetic peptide corresponding to the 14-carboxy-terminal residues of TrkA (arrows, lower panel). The broad range SDS ± PAGE molecular weight standards from Bio Rad were used to determine molecular weights.
The 145 000 dalton single form could be the mature, biologically active receptor. Both isoforms of around 110 000 dalton could correspond to intermediate glyc osylated forms and the 80 000 dalton molecule to the protein backbone, as happens for TrkA (Martin-Zanca e t a l, 1989).
Bind ing o f 125 I-NT-3 to tra nsd uce d a stro c yte s
The binding experiments were performed at 4 8C in order to avoid complex kinetics resulting from internalisation following binding. Transduced astrocytes were incubated with 125 I-NT-3 for 60 min, allowing equilibrium to be reached. Figure 5 shows the results obtained with 125 I-NT -3 at concentrations between 1 and 16´10 Ð 12 M. Analysis of the linear transformation resulting from the binding data, performed with the GraphPad Prism TM program, revealed a unique high af®nity saturable receptor with an equilibrium dissociation constant (K d ) of 4.1´10
Ð 11 M and further showed that there were a mean of 20 157 binding sites per cell. Our binding curve and data are similar to those reported for the high-af®nity NT-3 binding sites on embryonic chicken sensory neurons (11 126 receptors per cell with a K d of 1.8´10
Ð 11 M) (Rodrõ Âguez-T ebar e t a l, 1992) or the 45 000 p75 receptors acting with highaf®nity on sympathetic neurons, with a K d of 6´10
Ð 11 M (Dechant e t a l, 1997). As shown also in Figure 5 , no speci®c binding could be detected in astrocytes transduced with the AdRSVbGal negative control vector or in mockinfected cells, despite that a low level of expression of the truncated form of TrkC has been reported by Rudge e t a l, 1994. Therefore, it is likely that the binding sites found correspond to gp145 trkC receptors in the AdTrkC transduced cells.
Ind uc tio n o f DNA synth e sis
To determine if the transduced astrocytes were responsive to NT-3 via the TrkC receptor, we examined DNA synthesis by tritiated thymidine incorporation. As shown in Table 1 , addition of foetal calf serum to quiescent astrocytes infec ted 24 h before with AdTrkC, induc ed these cells to enter the S phase. Cells cultured in the absence of FCS or of any ligand (no addition) did not incorporate thymidine. Addition of different amounts of NGF and BDNF failed to elicit any detectable mitogenic response. The lower c.p.m. incorporation in the presence of NGF and BDNF was not statistically signi®cant when compared with the untreated astrocytes (Table 1) . However, when NT-3 was added to AdTrkC-transduced astrocytic cells, DNA synthesis was initiated, peaking at 20 ng/ml (Table 1) . Negative control cultures, provided by AdRSVbGal-transduced astrocytes, do not incorporate signi®cant amounts of tritiated thymidine when cultured in the presence of NT-3 (10 ± 50 ng/ml). These results clearly indicate that the AdTRkC-directed expression of TrkC confers mitogenic responsiveness to NT-3 to transduced astrocytes.
NT-3 bind ing e licits a uto p h o sp h o rylatio n o f gp145 trk C
We next examined whether the interaction of NT-3 with transduced gp145 trkC receptors elic its further func tional responses as autophosphorylation, in TrkC gene transfer by adenovirus N Rubio and J Abad-Rodriguezaddition to 3 Hthymidine incorporation. To do so, we used a monoclonal antibody that recognises phosphorylated tyrosine residues in Western analysis of cell homogenates. As shown in Figure 6 , incubation of isolated membrane from astrocytes transduced at different m.o.i. with 50 ng/ml NT-3 induced the rapid autophosphorylation of tyrosine residues in gp145 trkC . In contrast, we did not observe gp145 trkC phosphorylation when we used negative control AdRSVb Gal-infec ted astrocytic cell membranes (Figure 6 
Discussion
During nervous system development, neuronal populations reach a balance between the ®nal number of neurons and the sizes of its target territories. These target zones secrete limiting amounts of several neurotrophins that mediate survival, differentiation and function of neurons. The action of the neurotrophin family of neurotrophic factors is mediated mainly by the tyrosine kinase Trk receptors. These interactions are very speci®c; NGF binds TrkA, BDNF and NT-4 binds TrkB and NT-3 binds TrkC (Barbacid, 1995 This article evaluates the use of an adenovirus gene transfer vector for the in vitro delivery of the TrkC gene, coding for the high af®nity receptor for NT-3, into a nervous system cell population, such as the astrocytes. Our data demonstrate that the vector we constructed, AdTrkC, can ef®ciently transfer and drive the expression of the transgene in these glial cells maintained in tissue culture.
Following infection with our adenoviral vector at levels ranging from m.o.i. of 10 to 200 for 24 ± 48 h, we demonstrated that synthesis of TrkC-speci®c mRNA occurs by using reverse transcriptase-PCR and Northern blot analysis (Figures 2 and 3) . Bands migrating at the correct position in gels were found in AdTrkC-infected cells, but not in mock-infec ted astrocytes. When we separated by 2D elec trophoresis the proteins from transduced astrocytes and further used an anti-Trk antibody as a probe in Western blot, we detected the presenc e of a 145 000 dalton molecule, with an isoelectric point of 5.3, that is the putative gp145 trkC NT-3 receptor (Figure 4 , lower panel). In addition to that, the polypeptide backbone of around 80 000 dalton and several isoelectrically heterogeneous molecules, that could correspond to intermediate stages of glyc osylation, were detected by the antibody directed to the carboxy-terminal tail of Trk protein. Glycosylation of TrkA has been demonstrated to occur also at two different stages, presumably during its transport to the plasma membrane (Martin-Zanca e t a l, 1989).
A genuine fully active NT-3 receptor protein is translated from this mRNA as speci®c binding of 125 I-NT-3 could be measured in transduced cells. Conversely, no speci®c binding could be found in control mock-infec ted or AdRSVbGal-infec ted astrocytes ( Figure 5 ). In order to determine whether transduced astrocytes follow similar signal transduction pathways as cells expressing TrkC naturally, we studied whether the presenc e of NT-3 in the culture medium induces DNA synthesis and/or autophosphorylation of the de no vo created gp145 trkC . Indeed, a functional and speci®c response is elic ited as addition of recombinant NT-3 stimulates thymidine incorporation (T able 1), as well as rapid phosphorylation of tyrosine residues in gp145 trkC ( Figure 6 ). This functional response is fully speci®c as NGF and BDNF do not induce thymidine incorporation (Table 1) . No phosphorylation is detected either in astrocytes transduced by AdRSVb Gal (Figure 6 o) or in AdTrkC-transduced cells in the absence of NT-3 (not shown).
No apparent toxic effec ts were detected on the cultures due to infec tion. Furthermore, con¯uent non-dividing astrocyte cultures express TrkC, as detected by RT ± PCR, up to 1 month, the longest time tested. , were incubated for 10 min at 228C in the presence of 50 ng/ml of NT-3. After 8% SDSpolyacrylamide gel electrophoresis, samples were transferred to a nitrocellulose membrane and blotted with an anti-phosphotyrosine monoclonal antibody (mAb PY20) and a secondary horseradish peroxidase-coupled anti-mouse IgG, as described under Material and methods. The migration of gp145 trkC is indicated by an arrow.
The rationale of our choice of astrocytes instead of primary neurons is to induce fully active TrkC in nervous cells that never express it. Therefore, we do not expect that expression of TrkC in astrocytes would induc e profound biological responses as is the case for induc tion of new neurotrophin receptor expression in neurons. We have detected (a) changes in DNA synthesis and (b) receptor tyrosine phosphorylation, but not dramatic changes as migration, morphology changes or potent survival stimuli must be expected. Nevertheless, previous studies with NT-3 and TrkC knockout mice demonstrated a reduc tion in astrocyte cell markers in vivo . This fact suggests a role for NT-3 and its receptor as key regulators of normal astrocytic cell development (Kahn e t a l, 1999) .
There is an increasing interest in adenovirusmediated gene delivery as a tool for basic neuroscience research and treatment of several kinds of neurological disorders. Our results suggest that adenoviral vectors encoding neurotrophin receptors of the Trk family could be applied in the future for the local expression of receptors that, in combination with exogenous or endogenous neurotrophins, could promote regeneration of injured nervous tissue. Additional biological studies are undertaken to know if our vector could also assist in preventing the degeneration of some populations of neurons. Furthermore, some reports relate the expression of TrkC and good prognosis of tumours of nervous tissue origin (Ryden e t a l, 1996; Yamashiro e t a l, 1997; Grotzer e t a l, 2000); opening the possibility of the use of AdTrkC in the treatment of neuroblastomas and medulloblastomas.
Materials and methods
Co nstruc tio n o f th e a d e no viral ve c to r
The plasmid pFL19, generated in pB luescript (Stratagene, La Jolla, CA, US A) and encoding the full length TrkC gene of porcine origin (Lamballe e t a l, 1991 (Lamballe e t a l, , 1993 , was grown and puri®ed by using the Qiagen Plasmid Midikit (Qiagen Inc, Santa Clarita, CA, US A). The 2500 bp insert, coding for the 145 000 dalton gp145 trkC protein, was puri®ed from agarose gels after digestion with Xb a I and Cla I (Figure 1, 1) . The vector containing the ITR-Ad was puri®ed from agarose gels after Xb a I and Cla I digestion from pRSVb Gal (S tratford-Perricaudet e t a l, 1992) (Figure 1, 2) . The Rous sarcoma virus (RS V) promoter was puri®ed also from pRS Vb Gal after Xb a I and Cla I digestion (Figure 1, 3) . The recombinant plasmid pNR1 was constructed by T4 ligation of the TrkC insert with the vector containing the ITR-Ad. After linearization with Xb a I and PvuI, the promoter was ligated with T4 ligase to obtain the ®nal plasmid pNR2.
Construction of the recombinant adenoviral vector AdRSVTrkC (AdTrkC) was done by cotransfec ting 293 cells with linearized pNR2 and Cla I/ Xb a I restricted Ad5dl309 DNA by homologous recombination. Five l g of each partner DNA, Ase 1-linearized pNR2 and Cla I and Xb a I restriction digested Ad5 DNA (Yeh e t a l, 1996) , were cotransfec ted into near con¯uent 293 cells by the Ca 3 (PO 4 ) 2 method (Graham e t a l, 1977) . All restriction enzymes were purchased from Life Technologies S arl, Cergy Pontoise, France.
Viral sto c k p re p a ra tio n Viral stocks of AdRSVb Gal and AdTrkC were prepared from infected 293 cells by standard procedures (Stratford-Perricaudet e t a l, 1992) . Brie¯y, cells were infec ted and infection was allowed to proceed until complete detachment of the cell monolayer occurred (8 ± 12 days postinfection). The culture medium was then harvested, clari®ed and concentrated by ultra®ltration. Viruses were subsequently puri®ed by isopycnic CsCl ultracentrifugation, desalted on PD-1 0 desalting columns (Pharmacia Biotech, Uppsala, Sweden) and eluted in phosphate buffered saline (PB S ) before being aliquoted and stored at Ð 70 8C in PBS -10% glycerol. All viral stocks were titrated on 293 monolayers and their clonality was assessed by PCR.
Qua nti® ca tio n of b-gala c to sida se a ctivity
Infection controls were systematically included by counting the number of cells that scored positive following infection with AdRSVb Gal and X-gal staining. Monolayers of astrocytes were infected at a multiplicity of infection (m.o.i.) of 100 with the control AdRSVb Gal virus and incubated in the absence or presenc e of the chromogenic substrate X-gal (S igma Chemical Co, St Louis, MO, US A), at a ®nal concentration of 50 lg/ml, to score blue staining.
Astro c yte c ulture s
Astrocyte cultures were prepared by mechanical dissociation of the cerebral cortex of newborn Balb/ c mice (Rubio e t a l, 1990) . The cortex was isolated under a dissecting microscope and cleaned of choroid plexus and meninges. Cell suspensions were ®ltered through 80 l m pore mesh into Dulbec co's modi®ed Eagle medium (DMEM) containing 10% foetal calf serum (FCS ) and gentamicin (Flow Laboratories, Irvine, UK). After centrifugation, cells were ®ltered through a 20 lm mesh sieve, plated in 75 cm 2 tissue culture¯asks (Costar, Cambridge, MA, USA) and cultured at 378C. The medium was changed after 4 days of culture and subsequently three times a week for the entire culture period. Cultures were enriched in astrocytes by removal of less adherent oligodendrocytes by shaking for 18 h at 37 8C and 250 r.p.m. in a G24 environmental shaker (New Brunswick S cienti®c, Edison, NJ, USA). Cellular con¯uenc e was obtained 10 days after plating, and a polygonal¯at cell morphology was observed. A mean of 98% astrocytes was con®rmed by indirec t immuno¯uores-cenc e staining of methanol-®xed cultures with rabbit anti-glial ®brillary acidic protein (GFAP) antiserum (Dakopatts, Glostrup, Denmark) and uorescein-labelled goat anti-rabbit IgG (Miles Laboratories, Elkhart, IN, US A). The lack of noticeable oligodendrocytes and microglial/macrophage cells was determined by using a guinea-pig antimyelin basic protein (MBP) antiserum prepared as described elsewhere (Rubio and Cuesta, 1989 ) and a monoclonal anti-Mac-1 antibody (Serotec, Oxford, UK). S econdary¯uorescein-labelled antibodies against guinea-pig and rat IgG were purchased from Sigma.
PCR a na lysis
Total RNA was reverse-transcribed by using Moloney murine leukaemia virus reverse transcriptase (RT) (Promega, Madison, WI, US A) and the 3¢ ampli®er as template/primer. The amplimers used in the PCR reaction for TrkC ampli®cation were: 5¢: (5¢-GGGTGTGTGGTGATGGTGACCCACTCAT-CATGGTC-3¢); 3¢: (5¢-GCCAAGAATGTCCAGGTA-GATCGGGGTGGCCTTCC-3¢). Primer pairs for bActin were supplied by Promega.
PCR reactions were carried out for 40 cycles at an annealing temperature of 558C using a DNA Thermal Cycler 480 (Perkin-El mer Cetus, Emeryville, CA, US A). The resulting PCR products were puri®ed by using S -400 MicroSpin columns (Pharmacia Biotech) and electrophoresed in 2% NuS ieve agarose gels (FMC Bio Products, Rockland, ME, US A) in TAE buffer, stained with ethidium bromide and photographed in a Gelstation S ystem (TDI, Barcelona, S pain).
RNA iso la tio n a nd No rth e rn ana lysis
Astrocyte cell monolayers were infec ted in 75 cm 2 asks. Total RNA was puri®ed by using RNeasy Mini or Midi puri®cation kits (Qiagen). Ten micrograms of RNA per lane were denatured in formamide and formaldehyde and electrophoresed in MOPS (morpholinepropanesulphonic acid) buffer through 1% agarose-0.66 M formaldehyde gels and capillary blotted to Zeta-Probe nylon membranes (Bio-Rad Laboratories, Hercules, CA, US A). UV-cross linking, prehybridisation, hybridisation, and washing of the membranes were carried out as recommended by the supplier. Probes were labelled with 32 P-dCT P (Amersham Life S cienc e, UK) by using the random-primed method kit (Boehringer Mannheim, Germany). Unincorporated radiolabel was removed with S -300 MicroSpin columns (Pharmacia Biotech). The blots were exposed to Kodak X-OMAT ®lm with an intensifying screen (Hyperscreen, Amersham) at Ð 75 8C. A human bactin cDNA probe (Clontech, Palo Alto, CA, US A) was systematically included as a loading and transfer control. To ensure maximum homogeneity among the RNA samples, all RNA preparations to be compared were carried out in parallel.
The probe used for TrkC blotting was the 2500 bp insert puri®ed from pFL19 after Xb a I and Cla I digestion, as previously stated. After elec trophoresis in 2% agarose, the DNA band was excised from the agarose gel with a scalpel and puri®ed using the QIAEX II kit provided by Qiagen.
Two -d im ensio na l gel e lec tro p h o re sis
Proteins from cultured cells were solubilized with urea-4% NP-40 and subjected to two-dimensional, high resolution isoelectric focusing (IEF) and electrophoresis (2D), as originally described by O'Farrell (1975) . Brie¯y, ®rst-dimension gels in glass capillary tubes (4% acrylamide, 2% bisacrylamide, 9.5 M urea, 2% NP-40, 10.5 l l TEMED and 500 l l ampholines (LKB, pH 3.5 ± 10 and 5 ± 7 in a 1 : 1 ratio) per 10 ml of acrylamide solution) were polymerized by addition of 13 ll of 10% ammonium persulphate. The lower (anodic) reservoir contained 0.01 M H 3 PO 4 and the upper (cathodic) reservoir contained 0.02 M NaOH. Proteins were subjected to electrophoresis toward the anode at 400 V for 15 min and 750 V for 3.5 h. When the IEF run is completed, the gels were extracted from the tubes and the proteins were electrophoresed in a second-dimension 10% acrylamide-S DS slab gel according to Laemmli (Laemmli, 1970) .
We ste rn blots o f 2D ge ls 2D electrophoresis gels were blotted to nitrocellulose ®lters (Trans-Blot, Bio-Rad). Rabbit antiserum anti-pan-Trk raised against a synthetic peptide corresponding to the 14 carboxy-terminal residues of the deduced TrkA sequence (Ala Leu Ala Gln Ala Pro Pro Val Tyr Leu Asp Val Leu Gly) (Martin-Zanca e t a l, 1989) was used in a 1 : 300 dilution and horseradish peroxidase (HRP)-coupled secondary donkey anti-rabbit antibodies (Amersham) were diluted 1 : 2000. Blocking and incubation with antibodies were carried out in a solution of 5% powder milk in TNT (10 mM Tris pH 7.5, 150 mM NaCl, 0.05% Tween). Detection of the antibody was done with the ECL Western blot detection system (Amersham), according to the manufacturer's instructions.
Bind ing a ssa y
Human recombinant NT-3 (Promega, Madison, WI, US A) was labelled with lactoperoxidase (Sigma) and 125 I from Amersham, as described previously (Rodrõ Âguez-Tebar e t a l, 1992). Astrocytes cultured in 35 mm dishes (Costar) were used in the binding experiments. Three dishes were used for the determination of unspec i®c binding (preinc ubated for 30 min with a 100-fold excess of unlabelled NT-3) and three for the determination of total binding at each point. S pec i®c binding was determined by subtraction of unspec i®c from total binding. Bind-ing was performed with gentle horizontal shaking at 48C. The buffer used was Hank's Balanced S alt S olution (Flow) containing 0.2% bovine serum albumin (B S A) from Sigma. After washing three times with ice-cold buffer and drying at room temperature, cells were detached from the plastic surface with 2% S DS and counted in an LKB-Wallac 1282 Compugamma counter (Pharmacia Biotech). S catchard plot analysis of the data from binding assays was performed with the GraphPad Prism TM program (GraphPad S oftware, S an Diego, CA, US A).
Th ymid ine inco rp o ra tio n Cells in 96-well clusters (Costar) were infec ted with AdTrkC as previously stated and made quiescent by washing twice with serum-free DMEM followed by a 24 h incubation in DMEM containing 0.25% FCS . After adding the corresponding growth factors and incubating for 18 h, the cultures were pulsed with 1 l Ci of [ 3 H]thymidine per well (5 Ci/mmol, Amersham) for an additional 6 h period, washed once with cold PBS, trypsinized, and the amount of -free PBS , scraped and homogenised by 10 strokes of a Dounce homogeniser using a tight®tting pestle (Wheaton S cienti®c, Millville, NJ, US A) in 1.5 ml of homogenising buffer (20 mM HEPES buffer, pH 7.4, containing 1.5 mM MgCl 2 , 1 mM EGTA, 1 mM PMSF and 10 l g/ml leupeptin) at 4 8C. The lysates were centrifuged at 1500´g for 10 min at 48C and the resulting pellets were rehomogenised in 1 ml of homogenising buffer and recentrifuged as stated. The two supernatants of each membrane sample were pooled and further centrifuged at 30 000´g for 60 min at 48C. The pellets were resuspended in 100 ll of precooled 20 mM 2-N-morpholinoethanesulphonic acid (MES ) buffer (pH 7, containing 100 l g/ml leupeptin) and the protein concentration measured by the Bradford method (Bradford, 1976) using bovine IgG as standard. Membrane samples (25 l l, 25 l g of protein/sample) were incubated with 10 ll of NT-3 (®nal concentration, 50 ng/ml) in the presenc e of 10 ll of incubation buffer (120 mM HEPES , pH 7.5, 6 mM MnCl 2 , 60 l M ZnCl 2 , 180 l M Na 3 VO 4 ) for 10 min at 228C and then phosphorylated for 10 min at 4 8C with 5 ll of 50 mM ATP. The reaction was stopped by addition of 12 ll of 5´Laemmli's sample buffer. S amples were heated for 3 min in a boiling water bath, electrophoresed on an 8% PAGE ± S DS gel and subjec ted to Western blotting on nitrocellulose ®lters. The primary antibody used was anti-phospho-T yr mAb PY20 (S anta Cruz Inc., S anta Cruz, CA, USA) and the secondary antibody, horseradish peroxidase coupled-antimouse IgG mAb (S igma). S taining was made with the ECL system (Amersham) following the instructions of the manufacturer.
